ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39250-100mg |
|
1087-26-9 |
Hexyl gallate
|
0 | C13H18O5 | |
GC39250-10mM (in 1mL DMSO) |
|
1087-26-9 |
Hexyl gallate
|
0 | C13H18O5 | |
GC39249-100mg |
|
109351-33-9 |
(S)-Terazosin
|
0 | C19H25N5O4 | |
GC39249-50mg |
|
109351-33-9 |
(S)-Terazosin
|
0 | C19H25N5O4 | |
GC39249-10mg |
|
109351-33-9 |
(S)-Terazosin
|
0 | C19H25N5O4 | |
GC39249-5mg |
|
109351-33-9 |
(S)-Terazosin
|
0 | C19H25N5O4 | |
GC39249-10mM (in 1mL DMSO) |
|
109351-33-9 |
(S)-Terazosin
|
0 | C19H25N5O4 | |
GC39248-100mg |
|
1093861-60-9 |
Afoxolaner
|
0 | C26H17ClF9N3O3 | |
GC39248-50mg |
|
1093861-60-9 |
Afoxolaner
|
0 | C26H17ClF9N3O3 | |
GC39248-25mg |
|
1093861-60-9 |
Afoxolaner
|
0 | C26H17ClF9N3O3 | |
GC39248-10mg |
|
1093861-60-9 |
Afoxolaner
|
0 | C26H17ClF9N3O3 | |
GC39248-10mM (in 1mL DMSO) |
|
1093861-60-9 |
Afoxolaner
|
0 | C26H17ClF9N3O3 | |
GC39247-250mg |
|
115819-92-6 |
N-Hydroxypipecolic acid
|
0 | C6H11NO3 | |
GC39247-100mg |
|
115819-92-6 |
N-Hydroxypipecolic acid
|
0 | C6H11NO3 | |
GC39247-50mg |
|
115819-92-6 |
N-Hydroxypipecolic acid
|
0 | C6H11NO3 | |
GC39247-10mg |
|
115819-92-6 |
N-Hydroxypipecolic acid
|
0 | C6H11NO3 | |
GC39247-5mg |
|
115819-92-6 |
N-Hydroxypipecolic acid
|
0 | C6H11NO3 | |
GC39246-100mg |
|
1198151-75-5 |
Vapendavir diphosphate
|
0 | C21H32N4O11P2 | |
GC39246-50mg |
|
1198151-75-5 |
Vapendavir diphosphate
|
0 | C21H32N4O11P2 | |
GC39246-10mg |
|
1198151-75-5 |
Vapendavir diphosphate
|
0 | C21H32N4O11P2 | |